SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,531,000 | +18.4% | 115,696 | -2.3% | 1.17% | +36.4% |
| Q2 2022 | $3,827,000 | -2.4% | 118,476 | 0.0% | 0.86% | +0.5% |
| Q1 2022 | $3,922,000 | -6.8% | 118,476 | +19.8% | 0.85% | -13.9% |
| Q4 2021 | $4,207,000 | -14.3% | 98,904 | -10.7% | 0.99% | +1.0% |
| Q3 2021 | $4,908,000 | -4.8% | 110,767 | +22.1% | 0.98% | +7.2% |
| Q2 2021 | $5,155,000 | – | 90,738 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |